Exploring Strategies to Align Manufacturing of Stem Cell Derived Products to the Safety & Efficacy of the Product Whilst Meeting CMC Requirements

Time: 11:00 am
day: Conference Day 2


  • Illustrating ways to generate high quality induced pluripotent stem cells (iPSCs)
  • Understanding the specific differentiation into ventricular cardiomyocytes to minimize safety risks of the cells
  • Establishing a scalable manufacturing system to purify cardiomyocytes and reduce the cost of goods